RET and medullary thyroid gland carcinoma: For patients with known hereditary MTC, genetic risk stratification with RET testing is increasingly available, to determine the timing of prophylactic thyroidectomy.3 Approximately, 85% of mutations responsible for FMTC are now known and genetic testing detects nearly 100% of these.